Company News for June 29, 2009

• FBR Capital downgraded Alcoa (NYSE:AA - Snapshot Report) to "underperform" from "market perform," citing valuation and oversupply concerns

• According to an unidentified report of a clinical study out of Europe, insulin users of long-acting drugs showed increased cancer risks. Manufactures of such drugs include Sanofi Aventis (NYSE:SNY - Analyst Report) and Novo Nordisk (NYSE:NVO - Snapshot Report), while Amylin (NASDAQ:AMLN - Analyst Report) manufactures a non-insulin-based treatment

• According to news reports, Novartis (NYSE:NVS - Snapshot Report) is in talks to acquire parts of Elan (NYSE:ELN - Snapshot Report), including its multiple sclerosis drug Tysabri and its pipeline of Alzheimer's drugs